Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.
Clinical trial NCT01868477 · COMPLETED
Trial details
- NCT number
- NCT01868477
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-28
- Primary completion
- 2017-03-22
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.